1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Ovarian Cancer Research Program (OCRP) Clinical Trial Award is sponsored by Congressionally Directed Medical Research Programs (CDMRP). Supports rapid implementation of clinical trials with the potential to significantly impact ovarian cancer. Projects may range from small proof-of-concept trials through large-scale, definitive trials, including early-phase or pilot clinical trials in phase 0, 1, or 1/2.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
You are using an outdated browser. Please upgrade your browser to improve your experience. U.S. Department of War organization.
Due to routine system maintenance the CDMRP website will be unavailable from COB 24 April - 27 April COB.
DEPARTMENT OF WAR - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS Transforming Health Care through Innovative and Impactful Research Ovarian Cancer Research Program FY26 Ovarian Cancer Research Program (OCRP) same as CRRP Funding Page Synopsis of FY26 OCRP Award Mechanisms - (Adobe PDF) - provides a brief description and key elements of the award mechanism.
Program Announcement/Instructions Ovarian Cancer Academy - Early-Career Investigator Award Ovarian Cancer Clinical Trial Academy - Early-Career Investigator Award Synopsis of FY26 OCRP Award Mechanisms - (Adobe PDF) - provides a brief description and key elements of the award mechanism.
Program Announcement/Instructions Investigator-Initiated Research Award For further information, please send e-mail To: CDMRP Webmaster - for download-related questions Help@ebrap. org - for program announcement-related questions Last updated Thursday, July 16, 2026
According to the current listing, eligibility includes: Proposed projects may range from small proof-of-concept trials (e. g. Confirm the full requirements in the official notice before applying.
Ovarian Cancer Research Program (OCRP) Clinical Trial Award is funded by Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Minnesota Ovarian Cancer Alliance National Early Detection of Ovarian Cancer Research Awards 2026 is sponsored by Minnesota Ovarian Cancer Alliance (MOCA). MOCA will award multiple grants to support research on the early detection of ovarian, primary peritoneal, or fallopian tube cancer. Project funding is available for one year of activity.
Ovarian Cancer Clinical Trial Academy - Early-Career Investigator Award is sponsored by U.S. Army Medical Research Acquisition Activity; U.S. Army; Congressionally Directed Medical Research Programs (CDMRP). The OCCTA FY26 supports early-career investigators in ovarian cancer clinical trials through mentorship, networking, and research funding. This is highly relevant for university faculty and researchers.
The Congressionally Directed Medical Research Programs just released $1.27 billion across 34 programs. Universities, nonprofits, and small businesses are all eligible.
Read articleCDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article